← All news
Markets

Silence Therapeutics plc (SLN) Discusses Top-Line Results From SANRECO Phase II Trial of Divesiran in Polycythemia Vera Transcript

1 source ·2 articles ·Aug 11, 06:02 UTC Silence Therapeutics

Covered by 1 outlet

All coverage · 2 articles